Unveiling Patient Experiences in Testicular Cancer Clinical Trials
NCT ID: NCT05928377
Last Updated: 2023-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
500 participants
OBSERVATIONAL
2024-07-31
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Several people will be invited to enroll in this study so that it may collect a variety of data about testicular cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.
People with testicular cancer who are invited to take part in medical research will benefit from the analysis of the data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of the COVID-19 Pandemic on Testicular Cancer
NCT05083143
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
NCT06009549
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
NCT06070272
Analyzing Clinical Trial Experiences of Prostate Cancer Patients
NCT05411354
Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)
NCT02572934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of testicular cancer
* No prior treatment for testicular cancer
Exclusion Criteria
* Enrolled in another research study
* Inability to provide written informed consent
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Power Life Sciences Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael B Gill
Role: STUDY_DIRECTOR
Power Life Sciences Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Power Life Sciences
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Ljungman L, Eriksson LE, Flynn KE, Gorman JR, Stahl O, Weinfurt K, Wiklander M, Lampic C, Wettergren L. Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular Cancer: An Observational Study. J Sex Med. 2019 Jul;16(7):1049-1059. doi: 10.1016/j.jsxm.2019.05.005.
Selvi I, Sarikaya S, Basar H. Is testicular microlithiasis a really innocent condition? Its effects on oncological outcomes of germ cell testicular cancer: An observational study. Arch Esp Urol. 2020 Apr;73(3):215-229. English, Spanish.
Pedersen MR, Sloth Osther PJ, Nissen HD, Vedsted P, Moller H, Rafaelsen SR. Elastography and diffusion-weighted MRI in patients with testicular microlithiasis, normal testicular tissue, and testicular cancer: an observational study. Acta Radiol. 2019 Apr;60(4):535-541. doi: 10.1177/0284185118786063. Epub 2018 Jul 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
80505443
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.